Literature DB >> 6611552

Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.

L Rifas, V Shen, K Mitchell, W A Peck.   

Abstract

Rat resident peritoneal macrophages in primary culture were found to elaborate a mitogenic factor (or factors) for rat osteoblast-like cells and chondrocytes but not for skin fibroblasts. Growth-promoting activity appeared in the incubation medium within the first 20 hr of macrophage culture and was released in amounts that paralleled the number of macrophages per culture. After their proliferative response, as judged by increases in DNA synthesis and cell number, the osteoblast-like cells became enriched in alkaline phosphatase, an index of osteoblast specialization. The macrophage-derived activity was nondialyzable and heat-stable, and it was eliminated by exposure to trypsin. Inhibition of prostaglandin cyclooxygenase failed to modify its generation. Partial purification (Amicon filter concentration, gel filtration) disclosed principal peaks of activity corresponding to Mr of 43,000 and 10,000. The crude conditioned medium and the Mr 43,000-peak, but not the low-molecular-weight peak, exhibited interleukin 1 activity, as judged by the ability to stimulate the proliferation of mouse thymic lymphocytes. The macrophage-derived growth factor described herein may participate in bone remodeling and repair and in primary bone and cartilage growth.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611552      PMCID: PMC345630          DOI: 10.1073/pnas.81.14.4558

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells.

Authors:  D G Walker
Journal:  Science       Date:  1975-11-21       Impact factor: 47.728

2.  Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue.

Authors:  A J Kahn; D J Simmons
Journal:  Nature       Date:  1975-11-27       Impact factor: 49.962

3.  Activated macrophages induce vascular proliferation.

Authors:  P J Polverini; P S Cotran; M A Gimbrone; E R Unanue
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

4.  Purification and properties of human lymphocyte activating factor (LAF).

Authors:  G Blyden; R E Handschumacher
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  Bone cells: a serum-free medium supports proliferation in primary culture.

Authors:  J K Burns; W A Peck
Journal:  Science       Date:  1978-02-03       Impact factor: 47.728

7.  Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines.

Authors:  L B Lachman; M P Hacker; G T Blyden; R E Handschumacher
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

Review 8.  The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover.

Authors:  A M Parfitt
Journal:  Metabolism       Date:  1976-07       Impact factor: 8.694

9.  Spleen cells transmit osteopetrosis in mice.

Authors:  D G Walker
Journal:  Science       Date:  1975-11-21       Impact factor: 47.728

10.  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

View more
  14 in total

1.  The suppression of heterotopic ossification after total hip arthroplasty.

Authors:  H J Reis; W Küsswetter; T Schellinger
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

Review 2.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Elongation of fetal chick long bone in vitro is formed by a mitogenic activity preparation from porcine bone.

Authors:  K G Kukoschke; G Delling; H Mayer
Journal:  Calcif Tissue Int       Date:  1990-02       Impact factor: 4.333

4.  Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis.

Authors:  A Bensouyad; A P Hollander; B Dularay; A E Bedwell; R A Cooper; C W Hutton; P A Dieppe; C J Elson
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

5.  Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.

Authors:  S L Cheng; V Shen; W A Peck
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

6.  Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria.

Authors:  S Hanazawa; S Amano; K Nakada; Y Ohmori; T Miyoshi; K Hirose; S Kitano
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

7.  Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis.

Authors:  M Hüfner; H Döhner; J Schmidt; P Möller; A D Ho; W Hunstein
Journal:  Klin Wochenschr       Date:  1989-04-03

8.  A histochemical localization on Maclura pomifera lectin during osteogenesis.

Authors:  M Nakamura; H Akita; I Mizoguchi; M Kagayama
Journal:  Histochemistry       Date:  1989

Review 9.  Growth factors and the regulation of bone remodeling.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

10.  Effect of interleukin 1 beta on osteoblastic clone MC3T3-E1 cells.

Authors:  E Ikeda; M Kusaka; Y Hakeda; K Yokota; M Kumegawa; S Yamamoto
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.